Over a period of six months July – December 2014 during the consolidation phase of treatment for Acute Myeloid Leukaemia five patients at the Royal Adelaide Hospital and five patients at the Flinders Medical Centre received a daily dose of Cytarabine instead of a dose twice a day.

An independent review into the incorrect dosing of Cytarabine to ten patients with acute myeloid leukaemia was completed and a report with an Executive Summary and recommendations was finalised in November 2015. Health Consumers Alliance and Cancer Voices SA were members of the independent review process and panel.

The reports are available below.

Executive Summary - Independent review into the incorrect dosing of cytarabine

Full Report - Independent review into the incorrect dosing of cytarabine